Announcements Trials
Browse Landscape

Status

Recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Gastrointestinal 2CNS 2Tumor-Agnostic 1Thoracic 1Other solid neoplasm 1Gynecologic 1Breast 1

Conditions

Neuroblastoma 1Neoplasms 1Craniopharyngioma 1

Interventions

Temozolomide 165Magnetic Resonance Spectroscopy 130Radiotherapy 95Specimen Handling 80Radiosurgery 60Cyclophosphamide 55pembrolizumab 51Bevacizumab 51Nivolumab 48Radiation 47Carboplatin 34Biopsy 33Irinotecan 29Lomustine 25Etoposide 25Vincristine 23Topotecan 23Ipilimumab 23dinutuximab 21Cisplatin 21Blood Specimen Collection 21fludarabine 19Radiotherapy, Intensity-Modulated 19X-Rays 18Surgical Procedures, Operative 18abemaciclib 16Mental Status and Dementia Tests 16Granulocyte-Macrophage Colony-Stimulating Factor 16Pemetrexed 15atezolizumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Tumor Burden × CNS × 1 year × Clear all
NCT03610906 2026-03-23

Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy

University of Colorado, Denver

Enrolling by invitation
250 enrolled
CNS

Craniopharyngioma, Neoplasms

NCT00588068 2025-10-15

Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome

Memorial Sloan Kettering Cancer Center

Recruiting
2,070 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡